JAMCO Corporation (TYO:7408)
Japan · Delayed Price · Currency is JPY 1,794.00
+1.00 (0.06%)
Inactive · Last trade price on Jul 16, 2025
SpringWorks Therapeutics Revenue
In the fiscal year ending March 31, 2025, JAMCO had annual revenue of 79.00B JPY with 23.43% growth. JAMCO had revenue of 23.42B in the quarter ending March 31, 2025, with 19.42% growth.
Revenue
79.00B
Revenue Growth
+23.43%
P/S Ratio
0.61
Revenue / Employee
29.01M
Employees
2,723
Market Cap
48.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 79.00B | 15.00B | 23.43% |
| Mar 31, 2024 | 64.00B | 16.77B | 35.52% |
| Mar 31, 2023 | 47.23B | 8.15B | 20.85% |
| Mar 31, 2022 | 39.08B | -10.98B | -21.93% |
| Mar 31, 2021 | 50.06B | -41.48B | -45.31% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition